Expression of xCT as a predictor of disease recurrence in patients with colorectal cancer
Company-reported Phase 3 topline results have circulated in 20252026, and a regulatory filing has been anticipated, but retatrutide is not FDA- or EMA-approved and is not available as a prescription product
Your insurance may be able to cover the cost of your Vitamin B12 shots
Antioxidant phytochemicals for the prevention and treatment of chronic diseases
When applied together: A daily ritual of renewal, this cream isnt just skincareits an intimate dialogue with the bodys memory of youth
PCAC, the Pharmacy Compounding Advisory Committee, is meeting the FDA this week 10 of 12 members on the committee work in businesses aligned with peptides The PCAC recommendation is non-bindingMy take: Let the people inject themselves through regulated channels, via licensed providers and pharmacists There are millions of people injecting themselves with grey market peptides with zero oversight